Vets at Massachusetts Veterinary Referral Hospital describe how LexaGene’s beta prototype has excited them and given them a view of the future: rapid, in-clinic diagnostics that improve confidence in diagnosis, clinic workflow and patient outcome.
Dr. Jack Regan discusses LexaGene’s development of an antibiotic resistance panel to detect antibiotic resistance in pathogens in just one hour.
Take a short virtual tour of LexaGene and get an inside look at our state-of-the-art facilities.
LexaGene unveiled the LX2 prototype design to a veterinary diagnostics audience on October 20th, 2018 at the AAVLD Annual Meeting in Kansas City. LX2 Prototype design; Unveiling at Booth 203 by CEO Dr. Jack Regan; Veterinary diagnosticians engaging with LX2 technology.
Daryl Rebeck featured on Proactive Investors with Steve Darling at the LD Micro event on September 4, 2018.
Pinnacle Digest recently featured LexaGene in a podcast showcasing LexeGene’s new state-of-the-art labs and speaking with CEO Jack Regan.
Capital Ideas TV recently featured LexaGene CEO Jack Regan to discuss plans for commercialization of the LX6 system.
LexaGene President Daryl Rebeck featured on Capital Ideas TV, which aired on BNN 25 Feb 2018.
LexaGene is honored to be named a Top 50-Ranked TSX Venture company. Watch CEO Jack Regan’s interview with the TSX Venture Exchange
LexaGene describes the technology behind our fully automated, open-access pathogen detection device, the LX Analyzer.
LexaGene was featured on Innovations with Ed Begley Jr. which aired on Fox Business Network 8/26 and 9/9, 2017. Learn more about LexaGene by watching the segment.
At a conference in July 2017, LexaGene unveiled our LX6 alpha prototype to get early feedback from the food safety market.